Dermal filler: is a hollow, a bag or a dark circle the concern?
Dermal fillers add volume in selected areas. Under the eyes, a tear-trough hollow differs from protruding fat, malar swelling and pigment or visible vessels. These findings can coexist and require individual examination before choosing treatment. Filler does not address every cause of a dark circle, and its benefits must be weighed against risks.
Consultation information
On this page
What should be assessed before filler?
The clinician assesses the cause and reviews previous products, dates, reactions, eye problems, medicines and allergies. An unclear product history or existing swelling may change the plan. Product, treatment area and local authorisation must be checked individually. F1 F2
How do four lower-eye findings differ?
| Finding | Structure | Typical appearance | Assessment or option | Limit of filler alone |
|---|---|---|---|---|
| Tear-trough hollow | Lid-cheek contour and volume | A depression with a shadow | Selected cases may be considered for volume treatment | Does not resolve every cause of darkness. F2 |
| Protruding lower-lid fat | Orbital fat and eyelid support | A bulge or eye bag | Eyelid assessment; surgery may be discussed | Adding volume does not remove the protruding fat. F2 |
| Malar oedema or festoons | Fluid and tissues over the cheekbone | Swelling or folds below the lid | Identify the cause before any aesthetic procedure | Filler may worsen or prolong swelling; it is not a general solution. F2 |
| Pigment or visible vessels | Skin colour and underlying vessels | Darkness without a clear hollow | Assess the source of colour | Added volume does not directly treat pigment or vessels. F2 |
The table is not a self-diagnosis tool. The supporting review describes assessment principles, not a guarantee that a product or technique is best. Mixed findings may need another approach or no procedure. F2
When might treatment be unsuitable or postponed?
Active skin inflammation or infection should be assessed before injection. Relevant allergies, previous complications and ongoing swelling require discussion. Safety in pregnancy or breastfeeding is not established in the cited FDA guidance; review the actual product information with the clinician. F1 F2
What are the risks?
Bruising, swelling, pain, infection, lumps, persistent oedema or an unwanted result may occur. Accidental injection into a vessel can cause tissue damage, blindness or stroke. Removal may be difficult and has its own risks; reversibility must not be promised. F1 F2
How should results and follow-up be planned?
Discuss realistic benefit, alternatives including no injection, product-specific duration and how complications will be assessed. Some reactions appear later. A fixed amount, session count or perfect result cannot be selected from a photograph. F1 F2
Frequently asked questions
Will filler remove every dark circle?
No. Hollowing, colour, bulging fat and swelling require different assessments. F2
Is swelling always harmless?
No. Its timing and associated symptoms matter. New pain, skin-colour change or visual symptoms need immediate evaluation. F1 F2
Can all fillers be dissolved?
No. Removal depends on the material; some products are difficult or impossible to remove. Additional treatment has risks. F1
Does a foreign approval prove local suitability?
No. Approval is product- and site-specific. A US reference does not confirm Turkish authorisation or individual suitability. F1
Can I inject a product myself?
No. Do not self-inject or buy filler online for home use. Ask an appropriately qualified clinician about the product and its authorised source. F1